| Characteristics |
N |
Person months/100 |
Malaria cases |
Rate/100 person months |
Crude Rate ratio (95%CI) |
Adjusted rate ratio (95%CI) |
P-values |
LR |
| Age group |
<5years |
133 |
7.16 |
94 |
13.14 |
1 |
1 |
|
|
| 5-15years |
270 |
14.56 |
115 |
7.90 |
0.60 (0.46-0.79) |
0.73 (0.52-1.02) |
0.065 |
|
| >15 years |
234 |
12.50 |
25 |
2.00 |
0.15 (0.10-0.24) |
0.23 (0.14-0.40) |
0.001 |
|
| Ethnic group |
Fulani |
225 |
7.03 |
87 |
12.37 |
1 |
1 |
|
|
| Mandinka |
201 |
6.90 |
73 |
10.58 |
0.98 (0.72-1.34) |
0.56 (0.36-0.87) |
0.009 |
|
| Wolof |
200 |
6.46 |
69 |
10.68 |
0.92 (0.67-1.26) |
0.68 (0.45-1.01) |
0.059 |
|
| EIR |
Low |
90 |
5.17 |
20 |
3.87 |
1 |
1 |
|
|
| Medium |
409 |
21.87 |
154 |
7.04 |
1.82 (1.14-2.90) |
2.15 (1.23-3.78) |
0.008 |
|
| High |
138 |
7.18 |
60 |
8.35 |
2.16 (1.30-3.58) |
2.54 (1.29-4.97) |
0.007 |
|
| Bed net |
No |
473 |
25.36 |
164 |
6.47 |
1 |
1 |
|
|
| Yes |
164 |
8.87 |
70 |
7.89 |
1.22 (0.92-1.61) |
1.14 (0.82-1.59) |
0.435 |
|
| Eaves Gap |
No |
284 |
15.42 |
98 |
6.36 |
1 |
1 |
|
|
| Yes |
353 |
18.81 |
136 |
7.23 |
1.14 (0.88-1.47) |
1.26 (0.92-1.74) |
0.150 |
|
| Sickle cell genotype |
AS |
465 |
6.33 |
26 |
4.11 |
1 |
1 |
|
|
| AA |
117 |
25.02 |
184 |
7.36 |
1.79 (1.19-2.70) |
1.62 (1.05-2.51) |
0.030 |
|
| SS |
7 |
0.38 |
5 |
13.15 |
3.20 (1.23-8.33) |
2.47 (0.91-6.69) |
0.076 |
|
| G6PD deficient |
No |
570 |
30.53 |
211 |
6.91 |
1 |
1 |
|
|
| Yes |
32 |
1.71 |
6 |
3.51 |
0.51 (0.23-1.14) |
0.47 (0.21-1.09) |
0.079 |
|
| AMA1 Total IgG |
0 |
276 |
14.85 |
139 |
9.36 |
1 |
1 |
|
|
| >0 <260 |
87 |
4.69 |
35 |
7.46 |
0.80 (0.55-1.15) |
1.20 (0.78-1.85) |
0.399 |
|
| 260-729 |
88 |
4.73 |
18 |
3.80 |
0.41 (0.25-0.66) |
0.67 (0.39-1.15) |
0.143 |
X2=12.19
P=0.0160 |
| 730-1100 |
87 |
4.65 |
24 |
5.16 |
0.55 (0.36-0.85) |
0.98 (0.58-1.65) |
0.942 |
|
| >1100 |
88 |
4.72 |
9 |
1.91 |
0.20 (0.10-0.40) |
0.37 (0.17-0.79) |
0.010 |
|
| MSP119 Total IgG |
0 |
205 |
10.96 |
104 |
9.49 |
1 |
1 |
|
|
| >0 <60 |
105 |
5.58 |
55 |
9.85 |
1.04 (0.75-1.44) |
1.23 (0.82-1.85) |
0.312 |
|
| 61-220 |
106 |
5.70 |
38 |
6.67 |
0.70 (0.48-1.02) |
0.96 (0.63-1.46) |
0.850 |
|
| 221-840 |
105 |
5.64 |
18 |
3.19 |
0.34 (0.20-0.55) |
0.43 (0.23-0.81) |
0.008 |
X2=15.15 P=0.0044 |
| >840 |
106 |
5.82 |
11 |
1.89 |
0.20 (0.11-0.37) |
0.52 (0.26-1.03) |
0.062 |
|
| CSP Total IgG |
0 |
153 |
8.19 |
67 |
8.18 |
1 |
1 |
|
|
| >0 <200 |
117 |
7.31 |
46 |
6.29 |
0.89 (0.61-1.30) |
1.12 (0.74-1.70) |
0.592 |
|
| 210-600 |
118 |
4.85 |
31 |
6.40 |
0.59 (0.39-0.91) |
0.78 (0.49-1.25) |
0.306 |
X2=4.75
P=0.314 |
| 601-1050 |
118 |
7.45 |
47 |
6.31 |
0.91 (0.63-1.32) |
1.15 (0.75-1.76) |
0.513 |
|
| >1050 |
118 |
5.51 |
35 |
6.35 |
0.67 (0.45-1.01) |
0.79 (0.49-1.27) |
0.337 |
|
| |
TOTAL |
640 |
34.22 |
234 |
6.84 |
|
|
|
|
| LR: Logistic Regression; CI: Confidence Interval; X2: Chi squared; P: p-value; N: Number of individuals tested |
|
